If the results are good (as I and many here expect they are), what would the FDA want CytoDyn to do? Would the FDA want them to front run the results in a PR or would the FDA want them to confidentially present them to them in order to allow the FDA to work towards an EUA? I believe that the FDA would rather to work rationally and confidentially with CytoDyn than to have the CytoDyn mob harass the FDA while they are attempting to work toward an EUA or whatever they are working towards.
Also, would not bad results need to have been mentioned as a result of SEC rules? Not being mentioned, in my mind, takes that option off the table.